Е. Л. Насонов - Publications, H-index & Citations

Е. Л. Насонов

nasonova research institute of rheumatology

30H指数

756论文数

4.9K被引数

收录论文 88

发表时间

The impact of comorbidities on the efficacy of IL-6 inhibitor olokizumab compared to adalimumab in a randomized controlled trial 合并症对IL-6抑制剂olokizumab与adalimumab在随机对照试验中疗效影响的比较

Arthritis Research & Therapy

IF4.6

2025-11-18

OAAI

Eugen Feist; Michael E. Luggen; Evgeny L. Nasonov; Sergey S. Yakushin; Daria V. Bukhanova; Alina N. Egorova; Sergey A. Grishin; Mikhail Y. Samsonov; Josef S. Smolen

The role of Interleukin 6 inhibitors in therapy of severe COVID-19

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2020-11-01

OAAI

Nasonov, E.; Samsonov, M.

IL-6 AS A MARKER OF CORONARY ARTERY DISEASE IN RHEUMATOID ARTHRITIS PATIENTS WITH CARDIOVASCULAR RISK FACTORS

ATHEROSCLEROSIS

IF5.7

2018-08-01

PREAI

Fomicheva, O.; Krougly, L.; Sorokin, E.; Tsomartova, M.; Karpov, Y. U.; Gerasimova, E.; Novikova, D.; Popkova, T.; Nasonov, E.

SPECIFIC FEATURES OF SKIN INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS AND ASSOCIATED PULMONARY ARTERIAL HYPERTENSION

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2018-06-01

OAAI

Yudkina, N.; Volkov, A.; Martynyuk, T.; Nasonov, E.

POLYMORPHISMS OF HLA-DRB1 AND TNF-308 G/A ARE ASSOCIATED WITH RADIOGRAPHIC JOINT DESTRUCTION IN PATIENTS WITH VERY EARLY RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2018-06-01

OAAI

Guseva, I.; Smirnov, A.; Demidova, N.; Krylov, M.; Avdeeva, A.; Samarkina, E.; Luchikhina, E.; Karateev, E.; Abramov, D.; Nasonov, E.

Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial 类风湿关节炎患者皮下注射阿巴西普的长期安全性和有效性: IIIb期试验的5年结果

JOURNAL OF RHEUMATOLOGY

IF3.4

2018-04-15

OAAI

Genovese, Mark C.; Pacheco-Tena, Cesar; Covarrubias, Arturo; Leon, Gustavo; Mysler, Eduardo; Keiserman, Mauro; Valente, Robert M.; Nash, Peter; Abraham Simon-Campos, J.; Box, Jane; Legerton, Clarence W., III; Nasonov, Evgeny; Durez, Patrick; Elegbe, Ayanbola; Wong, Robert; Li, Xiaohui; Banerjee, Subhashis; Alten, Rieke

THE EFFECT OF ABATACEPT ON CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2017-06-01

OAAI

Borisova, M. A.; Lukina, G. V.; Sigidin, Y.; Luchihina, E. L.; Karateev, D. E.; Novikov, A.; Alexandrova, E.; Aronova, E.; Glukhova, S.; Nasonov, E.

NEW ORAL ANICOAGULANTS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME 抗磷脂综合征患者的新型口服抗凝剂

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2017-06-01

OAAI

Satybaldyeva, M. A.; Seredavkina, N.; Kashnikova, L.; Nasonov, E.; Reshetnyak, T.

COMPARISON OF EFFICACY AND SAFETY OF RITUXIMAB BIOSIMILAR, BCD-020, AND INNOVATOR RITUXIMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS REFRACTORY TO TNFA INHIBITORS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Eremeeva, A.; Chernyaeva, E.; Ivanov, R.; Nasonov, E.; Knyazeva, L.

SERUM LEVELS OF FAS/APO-1 AND FAS LIGAND (FASL) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Panafidina, T. A.; Sokhova, M. A.; Popkova, T. V.; Cherkasova, M. A.; Novikov, A. A.; Aleksandrova, E. N.; Nasonov, E. L.

GRADATION OF CHANGES IN AXIAL AND PERIPHERAL SKELETON WITH RESPECT TO THE AGE AT RHEUMATOID ARTHRITIS (RA) ONSET

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Dydykina, I.; Petrova, E.; Smirnov, A.; Marina, P.; Kovalenko, P.; Nasonov, E.; Vetkova, E.

CORONARY ARTERY STENOSIS IN PATIENTS WITH RHEUMATIOD ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Gerasimova, E.; Popkova, T.; Novikova, D.; Fomicheva, O.; Kolmakova, D.; Nasonov, E.

FIVE-YEAR SAFETY AND EFFICACY OF SUBCUTANEOUS ABATACEPT IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE RA AND AN INADEQUATE RESPONSE TO MTX: LONG-TERM EXTENSION OF THE PHASE III, DOUBLE-BLIND, RANDOMIZED ACQUIRE STUDY

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Genovese, M. C.; Tena, C. Pacheco; Covarrubias, A.; Leon, G.; Mysler, E.; Keiserman, M.; Valente, R.; Nash, P.; Simon-Campos, J. A.; Box, J.; Legerton, C. W., III; Nasonov, E.; Durez, P.; Elegbe, A.; Wong, R.; Li, X.; Banerjee, S.; Alten, R.

RITUXIMAB IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES ASSOCIATED WITH INTERSTITIAL LUNG DISEASE

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Khelkovskaya-Sergeeva, A. N.; Antelava, O. A.; Olyunin, Y. A.; Tarasova, G. M.; Lopatina, N. E.; Palshina, S. E.; Sazhina, E. G.; Nikonorova, N. O.; Koneva, O. A.; Alexandrovna, E. N.; Nasonov, E. L.

CYTOKINE PROFILES IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Novikov, A.; Aleksandrova, E.; Verizhnikova, Z.; Panafidina, T.; Popkova, T.; Karateev, D.; Luchihina, E.; Nasonov, E.

DIAGNOSTIC ACCURACY OF MULTIPLEX BEAD-BASED IMMUNOASSAY FOR ANTINUCLEAR ANTIBODIES (ANA) TESTING IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Aleksandrova, E.; Verijnikova, Z.; Novikov, A.; Panafidina, T.; Seredavkina, N.; Popkova, T.; Ayzina, N.; Nasonov, E.

DYNAMICS OF B LYMPHOCYTE SUBSETS IN SLE PATIENTS TREATED WITH RITUXIMAB

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Mesnyankina, A. A.; Aleksandrova, E. N.; Soloviev, S. K.; Aleksankin, A. P.; Glukhova, S. I.; Novikov, A. A.; Suponitskaya, E. V.; Aseeva, E. A.; Nasonov, E. L.

BONE MINERAL DENSITY CHANGES IN PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Gubar, E.; Dubinina, T.; Dyomina, A.; Godzenko, A.; Rumyantseva, O.; Smirnov, A.; Glukhova, S.; Urumova, M.; Erdes, S.; Nasonov, E.

RISK OF TYPE 2 DIABETES MELLITUS DEVELOPMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Kondratyeva, L.; Popkova, T.; Nasonov, E.